Breast cancer
Results
Phase 3
This trial compared trastuzumab (Herceptin) and chemotherapy, to Herceptin and chemotherapy followed by more Herceptin. It was for women with early breast cancer that was HER2 positive. This trial was supported by Cancer Research UK.
Recruitment start: 3 January 2008
Recruitment end: 16 December 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Judy fraser
Cancer Research UK
Cancer Research UK Clinical Trials Unit, Glasgow
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Sanofi
The Finnish Breast Cancer Group
This is Cancer Research UK trial number CRUKE/10/033.
Last reviewed: 25 March 2019
CRUK internal database number: 6063
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
